XML 37 R27.htm IDEA: XBRL DOCUMENT v3.26.3
Fair Value Measurement (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Financial Instruments Measured at Fair Value on a Recurring Basis
The following tables show the Company’s cash, cash equivalents, and short-term investments by significant investment category as of September 30, 2026 and December 31, 2025 (in thousands):
September 30, 2026
Amortized CostUnrealized GainsUnrealized LossesFair ValueCash and Cash EquivalentsShort-term Investments
Cash$8,065 $— $— $8,065 $8,065 $— 
Level 1:
Money market funds10,674 — — 10,674 10,674 — 
Level 2(1):
Commercial paper7,229 — (4)7,225 4,983 2,242 
Corporate debt15,061 2 (17)15,046 2,998 12,048 
U.S. treasury securities31,685 1 (37)31,649 2,493 29,156 
Subtotal53,975 3 (58)53,920 10,474 43,446 
Total$72,714 $3 $(58)$72,659 $29,213 $43,446 
December 31, 2025
Amortized CostUnrealized GainsUnrealized LossesFair ValueCash and Cash EquivalentsShort-term Investments
Cash$30,648 $— $— $30,648 $30,648 $— 
Level 1:
Money market funds17,156 — — 17,156 17,156 — 
Level 2(1):
Commercial paper13,035 2 — 13,037 2,989 10,048 
Corporate debt499 — — 499 — 499 
U.S. treasury securities16,863 6 — 16,869 — 16,869 
Subtotal30,397 8 — 30,405 2,989 27,416 
Total$78,201 $8 $— $78,209 $50,793 $27,416 
(1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments use inputs that are either directly or indirectly observable for the asset through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.